SECsense Logo

Caribou Biosciences, Inc. 8-K Filing: Key Updates for Investors on January 2, 2025

$CRBU
Form 8-K
Filed on: 2025-01-02
Source
Caribou Biosciences, Inc. 8-K Filing: Key Updates for Investors on January 2, 2025

Here are the key pieces of information extracted from the provided section of the financial report:

  1. Filing Type: The document is an 8-K filing, which is typically used to report major events that shareholders should know about.
  2. Company Information:
  • Name: Caribou Biosciences, Inc.
  • State of Incorporation: Delaware (DE)
  • Central Index Key (CIK): 0001619856
  • Exchange: NASDAQ
  • Stock Symbol: CRBU
  • Par Value: $0.0001 per share
  1. Address:
  • 2929 7th Street, Suite 105, Berkeley, CA 94710
  • Phone Number: 510-982-6030
  1. Reporting Period:
  • The report covers a specific date: January 2, 2025, indicating that the event or information reported pertains to this day.
  1. Filing Context:
  • The context ID is "c-1," which may refer to a specific reporting context within the filing.

Overall, this information indicates that Caribou Biosciences, Inc. filed an 8-K report on January 2, 2025, which is a significant date for the company. The report likely contains important updates or disclosures relevant to investors.